Literature DB >> 22948834

Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination.

Luigina Graziosi1, Andrea Mencarelli, Barbara Renga, Claudio D'Amore, Angela Bruno, Chiara Santorelli, Emanuel Cavazzoni, Francesco Cantarella, Emanuele Rosati, Annibale Donini, Stefano Fiorucci.   

Abstract

INTRODUCTION: Methionine dependency occurs frequently in tumor cells. Here we have investigated the effect of methionine deficiency on metastatic potential of gastric cancer cells in vitro and in vivo.
MATERIALS AND METHODS: Model of peritoneal carcinomatosis and xenograft was generated by intraperitoneal or subcutaneous implantation of gastric cancer cells in NOD-SCID mice. In comparison to control medium, 3-day culture of MKN45, MKN74, and KATOIII cells in a methionine-deficient medium inhibited cell proliferation, increased the rate of cell apoptosis, and reduced cell adhesion and migration. In the xenograft model induced by implantation of MNK45 and MNK74 cells, two cycles of methionine-deficient diet reduced the tumor growth. Further on, a 10-day cycle of methionine-deficient diet reduced the number of peritoneal nodules in the model of peritoneal carcinomatosis induced by MKN45 cells injection. Finally, a microarray analysis of the methylation of promoter CpG islets demonstrated that methionine deficiency reduced the promoter methylation of E-cadherin whose expression was markedly increased in vivo and in vitro.
RESULTS: In summary, we have provided evidence that a methionine-deficient diet modulates the growth of gastric tumor cells and in vitro deficiency of methionine increased apoptosis and decreased cellular adhesion and migration associated to epigenetic change of E-cadherin gene, in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948834     DOI: 10.1007/s11605-012-1996-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 3.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas.

Authors:  F Poirson-Bichat; R Lopez; R A Bras Gonçalves; L Miccoli; Y Bourgeois; P Demerseman; M Poisson; B Dutrillaux; M F Poupon
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

5.  Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro.

Authors:  Wei-Xin Cao; Jing-Min Ou; Xu-Feng Fei; Zheng-Gang Zhu; Hao-Ran Yin; Min Yan; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 6.  Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?

Authors:  D E Epner
Journal:  J Am Coll Nutr       Date:  2001-10       Impact factor: 3.169

7.  Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture.

Authors:  H Y Guo; H Herrera; A Groce; R M Hoffman
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

8.  The metabolic defect of methionine dependence occurs frequently in human tumor cell lines.

Authors:  J O Mecham; D Rowitch; C D Wallace; P H Stern; R M Hoffman
Journal:  Biochem Biophys Res Commun       Date:  1983-12-16       Impact factor: 3.575

9.  Necroptosis: a specialized pathway of programmed necrosis.

Authors:  Lorenzo Galluzzi; Guido Kroemer
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

10.  Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation.

Authors:  Valérie Pavillard; Abedalnaser A A Drbal; David J Swaine; Roger M Phillips; John A Double; Anna Nicolaou
Journal:  Biochem Pharmacol       Date:  2004-04-15       Impact factor: 5.858

View more
  6 in total

Review 1.  Targeting the methionine addiction of cancer.

Authors:  Joni C Sedillo; Vincent L Cryns
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Identification and verification of the role of crucial genes through which methionine restriction inhibits the progression of colon cancer cells.

Authors:  Liqiang Zhou; Zhiqing Chen; Chuan Liu
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

3.  CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.

Authors:  Andrea Mencarelli; Luigina Graziosi; Barbara Renga; Sabrina Cipriani; Claudio D'Amore; Daniela Francisci; Angela Bruno; Franco Baldelli; Annibale Donini; Stefano Fiorucci
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

4.  [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells].

Authors:  Liqiang Zhou; Shihao Li; Li Liu; Qi Zhou; Yiwu Yuan; Lin Xin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

5.  Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.

Authors:  Fabien Gay; Karine Aguera; Karine Sénéchal; Angie Tainturier; Willy Berlier; Delphine Maucort-Boulch; Jérôme Honnorat; Françoise Horand; Yann Godfrin; Vanessa Bourgeaux
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

6.  Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype.

Authors:  Vanessa Hearnden; Hilary J Powers; Abeir Elmogassabi; Rosanna Lowe; Craig Murdoch
Journal:  Eur J Nutr       Date:  2017-03-01       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.